Dasynoc Archives - Access Market Intelligence

Insights Newsletter

Always Be a Step Ahead

Learn the important healthcare trends that could affect you in advance. Get expert analysis and discover the innovative ideas that are helping businesses overcome today's challenges.

Subscribe to AMI's Insights Newsletter Today.
Login
Contact

Subscribe
Insights Newsletter

Always Be a Step Ahead

Learn the important healthcare trends that could affect you in advance. Get expert analysis and discover the innovative ideas that are helping businesses overcome today's challenges.

Subscribe to AMI's Insights Newsletter Today.
Login

cancer, Commercialization, Specialty Drug, Specialty HUBs

Xspray Pharma Partners with EVERSANA for Launch and Commercialization of Dasynoc (XS004)

Posted on February 28, 2023 by John Santilli

28
Feb

Xspray Pharma signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company’s first innovative cancer therapy Dasynoc

Continue reading →